Diabetics Face Increased Treatment-resistant Hypertension Risk
October 1, 2013|Type 2 Diabetes ICYMI
Author and Disclosure Information
Major finding: Diabetes patients with treatment-resistant hypertension had a 6.2% combined rate of death, myocardial infarction, and stroke over a 2-year period, compared with a 3.8% rate in nondiabetics.
Data source: The 3A registry, which enrolled nearly 15,000 patients with diabetes from 899 physician practices in Germany.
Disclosures: The German 3A registry is sponsored by Novartis. Dr. Friedrich said she had no relevant financial disclosures. Dr. Schmieder has been a consultant to, and a speaker on behalf of, Medtronic, which markets a renal denervation device.
AT THE EASD ANNUAL MEETING
To earn 0.25 hours AMA PRA Category 1 credit after reading this article, take the post-test here.
On Twitter @mitchelzoler
